Abstract PS11-05: Trastuzumab Deruxtecan in patients with HER2[+] or HER2-Low Advanced Breast Cancer and Pathologically Confirmed Leptomeningeal Carcinomatosis: Results from Cohort 5 of the DEBBRAH Study
Year: 2024
Type: conference-abstract
Source: Cancer Research
Authors: Marta Vaz Batista, José Manuel Pérez-García, Laia Garrigós, José Ángel García-Sáenz, Patricia Cortez-Castedo, Fabriccio Racca, Salvador Blanch, Manuel Ruíz - Borrego, Adela Fernández, María Fernández-Abad, Vega Iranzo, Maria Gion, Griselda Martrat, Daniel Alcalá-López, Jhudit Pérez-Escuredo, Miguel Sampayo-Cordero, Antonio Llombart-Cussac, Sofía Braga, Javier Cortés
Institutions: Hospital Prof. Dr. Fernando Fonseca, MedSIR (Spain), Hospital Universitario Dexeus, Hospital Clínico San Carlos, Hospital Ruber Internacional, Fundación Instituto Valenciano de Oncología, Hospital Universitario Virgen del Rocío, Universidad de Alcalá, Hospital Universitario Ramón y Cajal, Hospital General Universitario De Valencia, GEICAM – Spanish Breast Cancer Group, Hospital Arnau de Vilanova, Universidad Europea de Madrid
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4396599092